CHAUDHRY, FAISALM.D. NPI 1114189792 Clinician
Interventional Pain Management · TEMPLE TERRACE, FL
- SPORTS AND ORTHOPEDIC REHABILITATION SERVICES INC — NEW PORT RICHEY, FL
- TALLAHASSEE ORTHOPEDIC CLINIC III PL — TALLAHASSEE, FL
Group affiliation since 2019
The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.
Year: 2024 · 2023 · 2022 locked column · 2021 locked column · 2020 locked column
Provider overview · all codes · CY2024
The full analytics for this provider
PremiumThe billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.
- Payment, service & beneficiary totals — the disclosed scale, all codes
- Practice profile — focus & reach — top codes by share of services
- Office vs. facility setting mix — place-of-service code split
- Volume over five years — discrete yearly counts, no rate
- Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
- Peer positioning — code breadth — how many codes billed, vs peers
Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.
Notify me at launch → Or see a live example profile →Procedures billed to Medicare Part B (2024)
Medicare Part B FFS · CY2024 · as published by CMS| Code | Description | Services locked column | Beneficiary-episodes locked column | Avg charge locked column | Avg Medicare payment locked column |
|---|---|---|---|---|---|
| J1010 | Injection, methylprednisolone acetate, 1 mg | premium | premium | premium | premium |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | premium | premium | premium | premium |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | premium | premium | premium | premium |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | premium | premium | premium | premium |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | premium | premium | premium | premium |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | premium | premium | premium | premium |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | premium | premium | premium | premium |
| 72148 | Mri scan of lower spinal canal without contrast | premium | premium | premium | premium |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | premium | premium | premium | premium |
| 99203 | New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more | premium | premium | premium | premium |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | premium | premium | premium | premium |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | premium | premium | premium | premium |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | premium | premium | premium | premium |
| 72110 | X-ray of lower and sacral spine, minimum of 4 views | premium | premium | premium | premium |
| 62323 | Injection of substance into lower spine canal using imaging guidance | premium | premium | premium | premium |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | premium | premium | premium | premium |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | premium | premium | premium | premium |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | premium | premium | premium | premium |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | premium | premium | premium | premium |
| 64625 | Destruction of nerves supplying joint between spine and pelvis using imaging guidance | premium | premium | premium | premium |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | premium | premium | premium | premium |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | premium | premium | premium | premium |
| 64628 | Heat destruction of intraosseous basivertebral nerve in bones of spine in lower back, first two bones | premium | premium | premium | premium |
| 72141 | Mri scan of upper spinal canal without contrast | premium | premium | premium | premium |
| 64629 | Heat destruction of intraosseous basivertebral nerve in additional bone of spine in lower back | premium | premium | premium | premium |
| 72146 | Mri scan of middle spinal canal without contrast | premium | premium | premium | premium |
| 72050 | X-ray of upper spine, 4-5 views | premium | premium | premium | premium |
| 99212 | Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more | premium | premium | premium | premium |
These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.